Moderna Inc

Moderna Inc said on Friday it has submitted for conditional approval of a booster dose of its COVID-19 vaccine at a 50 microgram dose level to the EU drugs regulator. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Sriraj Kalluvila)

The United States on Thursday shipped more than 2 million doses of Moderna's COVID-19 vaccine to Kenya and Ghana on Thursday through the COVAX global distribution program, a White House official said.

The United States will begin shipping more than 2 million doses of Moderna's COVID-19 vaccine to Kenya and Ghana on Thursday through the COVAX global distribution program, a White House official said.

Moderna Inc on Wednesday asked the U.S. Food and Drug Administration (FDA) to allow the use of a third booster dose of its COVID-19 vaccine.

Moderna Inc said on Wednesday it had initiated submission of data to the U.S. Food and Drug Administration (FDA) for the evaluation of a booster dose of its COVID-19 vaccine.

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review.

The United States has administered a third dose of either Pfizer Inc-BioNTech or Moderna Inc's COVID-19 vaccines to over 1 million people since Aug. 13, when regulators authorized an additional shot for immunocompromised people.

The United States has administered a third dose of either Pfizer Inc or Moderna Inc's COVID-19 vaccines to over 1 million people as of Wednesday morning, the U.S. Centers for Disease Control and Prevention said.

Moderna Inc and Takeda Pharmaceutical Co Ltd on Wednesday said they are working with Japanese authorities to recall three batches of COVID-19 vaccine after an investigation found stainless steel contaminants in some vials.

Britain will give severely immunosuppressed people a third dose of COVID-19 vaccine to increase their chances of generating a better immune response, although officials stressed the offer was separate from any broader booster vaccine programme.

Japan reported a fresh contamination case involving Moderna's COVID-19 vaccine, the fourth such incident in less than a week, threatening to slow the country's sputtering inoculation campaign.

Moderna Inc said on Wednesday its Japanese distribution partner, Takeda Pharmaceutical Co Ltd, planned to initiate the recall of three lots of its COVID-19 vaccine that were suspended due to contamination.

Japan's health ministry said on Wednesday that contaminants found in suspended Moderna Inc COVID-19 vaccines were particles of stainless steel, and it did not expect they would pose an additional health risk.

Japan's Kanagawa prefecture said it has found another vial of Moderna Inc's COVID-19 vaccine suspected of containing a foreign substance and has put the rest of the lot on hold.

Japan's COVID-19 vaccination push suffered a blow from widening reports of contamination in supplies of Moderna Inc's vaccine.

Japan's health minister said on Tuesday it was highly likely that foreign matter found in Moderna Inc COVID-19 vaccines in the southern prefecture of Okinawa were caused when needles were stuck into the vials.

Moderna Inc's COVID-19 vaccine contamination woes in Japan widened after two regions put temporary holds on shots following the discovery of foreign substances in more batches.

The U.S. Centers for Disease Control and Prevention said no deaths had been reported in young adults after a rare heart inflammation known as myocarditis, a known side effect of COVID-19 vaccines made by Pfizer Inc and Moderna.

Japan's COVID-19 vaccination push has been dealt a blow by widening reports of contamination in supplies of Moderna Inc's COVID-19 vaccine.